This week, CancerNetwork review an article published in the July issue of the journal ONCOLOGY titled, “Level of Scientific Evidence Underlying the National Comprehensive Cancer Network Clinical Practice Guidelines for Hematologic Malignancies.” CancerNetwork spoke with Thejaswi Poonacha, MD, MBA, a staff physician and hospitalist in the department of internal medicine at the University of Minnesota Medical Center, regarding the research from him and his colleagues. The conversation focused on t...
Aug 02, 2021•15 min•Season 1Ep. 29
CancerNetwork spoke with Kami Maddocks MD, an associate professor of clinical internal medicine in the Division of Hematology at The Ohio State University, about CD-19 directed agents, avoiding rechallenging with rituximab, and second-line outcomes for transplant-ineligible patients with diffuse large B-cell lymphoma (DLBCL). Visit cancernetwork.com to check out the first episode of this 3-part series here . Don’t forget to subscribe to the "Oncology Peer Review On-The-Go" podcast on Apple Podca...
Jul 30, 2021•14 min•Season 2Ep. 7
This week, CancerNetwork® examined an article from the June issue of the journal ONCOLOGY® titled “ Second-Line Therapies in the Changing Landscape of First-Line Therapies for Metastatic Clear Cell Renal Cell Cancer ” by speaking with one of the authors, Robert A. Figlin, MD. Figlin, who is a professor of medicine and biomedical sciences, Steven Spielberg Family Chair in Hematology-Oncology, and deputy director of Cedars-Sinai Cancer at the Cedars-Sinai Medical Center in Los Angeles, California,...
Jul 19, 2021•16 min•Season 1Ep. 28
As part of its OncView™ video series, CancerNetwork® spoke with Benjamin Levy, MD, of the John Hopkins Sidney Kimmel Comprehensive Cancer Center, to discuss frontline management of extensive-stage small cell lung cancer (SCLC) and the recent updates in the field. In the video series, Levy discussed the following: · Small Cell Lung Cancer: Risk and Prognosis · Small Cell Lung Cancer: Standard of Care · Extensive-Stage Small Cell Lung Cancer: Gaps in Treatment · Immunotherapy for First-Line Extens...
Jul 16, 2021•35 min•Season 2Ep. 6
In this episode, CancerNetwork spoke with 2 experts on the topic of biosimilars, Howard Hochster, MD, FACP, Associate Director for Clinical Research at the Rutgers Cancer Institute of New Jersey and Distinguished Professor of Medicine at the Rutgers School of Medicine, and Michael Kane, RPh, BCOP, Executive Director of Oncology Pharmacy Services for RWJBarnabas Health and Director of Pharmacy Services and the Research Pharmacy at the Rutgers Cancer Institute of New Jersey. The episode dives into...
Jul 05, 2021•28 min•Season 1Ep. 27
In this episode, CancerNetwork spoke with Gilles Salles, MD, PhD, Chief of the Lymphoma Service at Memorial Sloan Kettering Cancer Center in New York, about recently approved and emerging treatment regimens for transplant-ineligible diffuse large B-cell lymphoma (DLBCL). Salles discussed some of the available treatment options including tafasitamab, CAR T-cell therapies, selinexor, and antibody drug conjugates (ADCs). He also looked ahead at some of the upcoming research on the horizon, includin...
Jun 30, 2021•27 min•Season 2Ep. 5
As part of the OncView video series, CancerNetwork spoke with Mark Socinski, MD, of the AdventHealth Cancer Institute in Orlando, Florida about updates in the management of extensive-stage small cell lung cancer (ES-SCLC). Socinski touched on a number of important aspects of treating this disease, including the existing standards of care, treatment challenges, immunotherapy, IMpower 133 trial, and more. Don’t forget to subscribe to the "Oncology Peer Review On-The-Go" podcast wherever you get yo...
Jun 28, 2021•28 min•Season 2Ep. 4
This week, "Oncology Peer Review On-The-Go" discussed an article from the May issue of the journal ONCOLOGY titled “Molecular Profiling Practices in Pancreatic Adenocarcinoma: Academic vs Community Physicians.” CancerNetwork spoke with Christine Chung, DO, from the HCA Swedish Medical Center in Englewood, Colorado, about the molecular profiling patterns she and her colleagues observed in this retrospective review. The authors found that both academic and community physicians ordered profiling ab...
Jun 21, 2021•30 min•Season 1Ep. 26
As part of its OncView™ video series, CancerNetwork® spoke with Sameh Gaballa, MD, of the Moffit Cancer Center, about current and future treatment options, and considerations for patients with relapsed/refractory follicular lymphoma. In the video series, Gaballa discussed the following:· Treatment Options in Relapsed/Refractory Follicular Lymphoma · Considerations for Treatment Selection in R/R FL · Third-Line Therapy in Follicular Lymphoma · Tazemetostat for Relapsed/Refractory Follicular Lymph...
Jun 17, 2021•29 min•Season 2Ep. 3
The May issue of the journal ONCOLOGY featured a review article titled “Primary Focal Therapy for Localized Prostate Cancer: A Review of the Literature.” Sudhir Isharwal, MD, an assistant professor in the Department of Urology at Oregon Health & Science University in Portland, Oregon, discussed the emergence of focal therapies in the last few years for the treatment of patients with localized prostate cancer. This literature review investigated some of the advantages and drawbacks of various...
Jun 07, 2021•27 min•Season 1Ep. 25
The feature article for this episode comes from the April issue of the J ournal ONCOLOGY titled “Treatment Considerations for Transplant-Ineligible Multiple Myeloma.” Sarah Holstein, MD, an associate professor of internal medicine in the Division of Oncology & Hematology at University of Nebraska Medical Center in Omaha, Nebraska, spoke about the need for further research into treatment options for the older and more frail patient population of multiple myeloma. Holstein also explained the i...
May 24, 2021•14 min•Season 1Ep. 24
As part of its OncView video series, CancerNetwork spoke with Reshma L. Mahtani, DO, Sylvester Comprehensive Cancer Center, about the current role of genomic testing in HR-positive breast cancer and guidance on the use of genomic assays to individualize therapy in the extended adjuvant setting. In the video series, Gadi discussed the following:· Extended Adjuvant Therapy for HR+ Breast Cancer · NCCN Updates to Genomic Testing in HR+ Breast Cancer · Genomic Testing for HR+ Breast Cancer: Best Pra...
May 19, 2021•17 min•Season 2Ep. 2
As part of its OncView video series, CancerNetwork spoke with Vijayakrishna (VK) Gadi, MD, PhD, University of Illinois College of Medicine, about the current role of genomic testing in HR-positive breast cancer and guidance on the use of genomic assays to individualize therapy in the extended adjuvant setting. In the video series, Gadi discussed the following:· Adjuvant Vs Extended Adjuvant Therapy in HR+ Breast Cancer · Predictive and Prognostic Factors in HR+ Breast Cancer · Role of Genomic Te...
May 18, 2021•26 min•Season 2Ep. 1
This episode features an article published in the April issue of the Journal ONCOLOGY titled “Focus on Transitional Disease: A Critical Interval to Delay Progression of Prostate Cancer.” The lead author of the research, E. David Crawford, MD, a urologic oncologist, and professor of urology at the University of California San Diego, explained their research into prostate cancer disease states. Among other things, Crawford and the research team talked about next-generation imaging, biomarkers, and...
May 10, 2021•36 min•Season 1Ep. 23
This episode features an article published in the Journal ONCOLOGY titled “Integrating PARP Inhibitors Into Advanced Prostate Cancer Therapeutics.” CancerNetwork spoke with the corresponding author, Jun Gong, a medical oncologist at Cedars-Sinai Medical Center, to discuss the 4 PARP inhibitors that have undergone significant investigation for the treatment of patients with metastatic castrate-resistant prostate cancer. While elaborating on these PARP inhibitors, Gong also discussed the importanc...
Apr 26, 2021•15 min•Season 1Ep. 22
In this episode, CancerNetwork sat down for a conversation with David Johnson, chairman and CEO of Enveric Biosciences. Johnson gave a thorough background of the biosciences company, and detailed the endocannabinoid products Enveric is developing to positively impact the quality of life for patients with glioblastoma. Don’t forget to subscribe to the "Oncology Peer Review On-The-Go" podcast anywhere podcasts are available.
Apr 12, 2021•16 min•Season 1Ep. 21
This episode of the "Oncology Peer Review On-The-Go" podcast centers around an article publishing in the April issue of the Journal ONCOLOGY , titled “Messenger RNA Vaccines-Beckoning of a New Era in Cancer Immunotherapy.” The article touches on the recent development of mRNA vaccines approved to combat COVID-19, and how this development offers optimism for the future of mRNA to treat patients with cancer. The author, Mehmet Sitki Copur, MD, of the University of Nebraska Medical Center, broke do...
Mar 29, 2021•27 min•Season 1Ep. 20
In this episode, CancerNetwork examines an article from the March issue of the Journal ONCOLOGY titled “Factors Associated With Treatment Refusal and Impact of Treatment Refusal on Survival of Patients With Small Cell Lung Cancer.” The original research article found that treatment refusal among patients with small cell lung cancer was associated with worse survival, and strategies to increase patient acceptance of the recommended treatment need to be studied further. CancerNetwork spoke with on...
Mar 15, 2021•24 min•Season 1Ep. 19
This week, CancerNetwork sat down for a 1-on-1 conversation with former Chief Medical Officer and Executive Vice President of ASCO, Richard Schilsky, MD, to discuss ASCO’s 2021 "Advance of the Year," molecular profiling driving progress in gastrointestinal cancers. Schilsky discussed the progress being made in this field and the top research contributing to the momentum in gastrointestinal cancers, while also elaborating on health equity in cancer research, ASCO’s top research priorities moving ...
Mar 01, 2021•18 min•Season 1Ep. 18
This week, CancerNetwork examined a review article published in the February issue of the Journal ONCOLOGY titled “Utility of the 21-Gene Recurrence Score in Node-Positive Breast Cancer.” The piece highlights the existing literature regarding the prognostic and predictive capabilities of the 21-gene recurrence score in patients with node-positive breast cancer, focusing on current practice patterns and emerging applications from the surrounding literature. For the summary, CancerNetwork spoke wi...
Feb 15, 2021•32 min•Season 1Ep. 17
This week, CancerNetwork spoke with Justin Gregg, MD, about a study published in Cancer titled “Adherence to the Mediterranean diet and grade group progression in localized prostate cancer: An active surveillance cohort.” Gregg, an assistant professor of urology at The University of Texas MD Anderson Cancer Center and the lead author of the study, explained that the Mediterranean diet was associated with a lower risk of Gleason Grade group progression among men with localized prostate cancer on ...
Feb 01, 2021•11 min•Season 1Ep. 16
In this episode, CancerNetwork speaks with Ashwatha Narayana, MD, a professor and chairman of radiation oncology at Northern West Chester Hospital. Narayana co-authored a review article titled “Guidelines for Palliative Treatment of Spinal Metastases: Choosing Between Stereotactic Body Radiation Therapy and Conventional Fractionation.” The article published in the January issue of the Journal ONCOLOGY and discusses the surrounding literature regarding palliative radiation therapy for spinal meta...
Jan 18, 2021•14 min•Season 1Ep. 15
In the first episode of 2021, CancerNetwork spoke with Che-Kai Tsao, MD, a medical oncologist at Mount Sinai. Tsao discussed smoking cessation, its relation to cancer, and screenings for patients. More, he went into detail regarding the National Cancer Institute-funded smoking cessation program, a program Mount Sinai has been a part of for a number of years. Don’t forget to subscribe to the "Oncology Peer Review On-The-Go" podcast on Apple Podcasts, Spotify or anywhere podcasts are available....
Jan 04, 2021•11 min•Season 1Ep. 14
In this episode of "Oncology Peer Review On-The-Go", CancerNetwork takes a look at an article publishing in early 2021 for the Journal ONCOLOGY , titled “Patient-Reported Outcomes of Pain and Related Symptoms in Integrative Oncology Practice and Clinical Research: Evidence and Recommendations.” The piece summarizes current and validated patient-reported outcomes (PROs) specific to cancer-related pain. The piece also recommends commonly used PROs to be standardized to aid integrative oncology cli...
Dec 21, 2020•41 min•Season 1Ep. 13
In this edition of "Oncology Peer Review On-The-Go," CancerNetwork spoke with Zuri Murrell, MD, for a conversation regarding the rising rates of colorectal cancer for younger individuals, as well as the significantly higher incidence and death rates for black patients of this cancer type. Murrell, a colorectal surgeon and cancer specialist at Cedars-Sinai, explained that obesity, diabetes, smoking, and a family history of colorectal cancer may all play a role in the increasing rate. Don’t forget...
Dec 07, 2020•33 min•Season 1Ep. 12
This latest episode of "Oncology Peer Review On-The-Go" looks at an article published in the November issue of the journal ONCOLOGY , titled “Supporting Decision-Making on Fertility Preservation Among Adolescent and Young Adult Women With Cancer.” The piece examines oncofertility, unexpected cancer diagnoses and the decision-making process for young adult patients. For a breakdown of the article, CancerNetwork spoke with co-author of the review article, Jackelyn Payne, MPH, MA, a doctoral studen...
Nov 23, 2020•32 min•Season 1Ep. 11
This episode of "Oncology Peer Review On-The-Go" examines an article published in the October issue of the journal ONCOLOGY , titled “Barriers to Clinical Trial Enrollment in Patients With Pancreatic Adenocarcinoma Who Are Eligible for Early-Phase Clinical Trials.” The piece was written by Rachael Galvin, DO, MPH, Christine Chung, DO, Ella Achenbach, Oliwier Dziadkowiec, PhD, and Shiraj Sen, MD, PhD, and focuses on what keeps patients of this aggressive form of pancreatic cancer from pursuing en...
Nov 09, 2020•29 min•Season 1Ep. 10
This episode of “Oncology Peer Review On-The-Go” examines an article published in the October issue of the journal ONCOLOGY , titled “Considerations for the Management of Oncology Patients During the COVID-19 Pandemic.” The piece focuses on the management of the coronavirus pandemic and best practices to effectively manage patients with cancer. For detailed information regarding the article, CancerNetwork spoke with two authors of the study, Jeffrey Schneider, MD, and Marc Braunstein, MD, PhD, f...
Oct 26, 2020•33 min•Season 1Ep. 9
This episode of "Oncology Peer Review On-The-Go" features an article published in the September issue of the journal ONCOLOGY. The article is titled “Screening for Phase 1 Clinical Trials: An Opportunity to Evaluate Psychological States and Re-educate Patients on Prognosis?” It was written by Sarah Moreland, MD, and Shiraj Sen, MD, PhD, and focuses on physician-patient communication and the psychosocial impact of cancer diagnoses on patients. For more information regarding the article, CancerNet...
Oct 12, 2020•37 min•Season 1Ep. 8
This episode of "Oncology Peer Review On-The-Go" examines a review article published in the September issue of the journal ONCOLOGY . The article, “Molecular Profiling in Metastatic Colorectal Cancer,” was written by Samantha Armstrong, MD, Rita Malley, MS, and Benjamin Weinberg, MD. The piece discusses the epidemiology, tumor location, and mutational landscape of metastatic colorectal cancer. For an in-depth evaluation of that piece, CancerNetwork spoke with Armstrong and Weinberg from the Geor...
Sep 28, 2020•25 min•Season 1Ep. 7
